Saber İmani

2.2k total citations · 1 hit paper
81 papers, 1.5k citations indexed

About

Saber İmani is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Saber İmani has authored 81 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 21 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Saber İmani's work include MicroRNA in disease regulation (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Saber İmani is often cited by papers focused on MicroRNA in disease regulation (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Saber İmani collaborates with scholars based in China, Iran and United States. Saber İmani's co-authors include Junjiang Fu, Hossein Hosseinifard, Jingliang Cheng, Ray‐Chang Wu, Chunli Wei, Shangyi Fu, Qinglian Wen, Marzieh Dehghan Shasaltaneh, Yunes Panahi and Youcai Deng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Saber İmani

79 papers receiving 1.5k citations

Hit Papers

Computational biology and artificial intelligence in mRNA... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saber İmani China 23 776 394 276 184 179 81 1.5k
Yiwei Wang China 23 895 1.2× 259 0.7× 253 0.9× 170 0.9× 207 1.2× 75 1.6k
Luiz Eurico Nasciutti Brazil 28 738 1.0× 344 0.9× 212 0.8× 206 1.1× 299 1.7× 88 2.1k
Yan Du China 19 649 0.8× 256 0.6× 321 1.2× 194 1.1× 317 1.8× 53 1.4k
Shanshan Yang China 20 786 1.0× 384 1.0× 335 1.2× 168 0.9× 203 1.1× 79 1.6k
Jialing Zhang China 21 763 1.0× 349 0.9× 220 0.8× 166 0.9× 89 0.5× 65 1.4k
Yulai Zhou China 24 759 1.0× 220 0.6× 204 0.7× 189 1.0× 207 1.2× 69 1.5k
Xingyu Liu China 24 761 1.0× 284 0.7× 340 1.2× 368 2.0× 218 1.2× 129 1.7k
Panpan Zhang China 25 1.2k 1.5× 573 1.5× 185 0.7× 131 0.7× 256 1.4× 138 1.9k
Jérôme Zoidakis Greece 25 839 1.1× 211 0.5× 200 0.7× 182 1.0× 270 1.5× 88 1.7k

Countries citing papers authored by Saber İmani

Since Specialization
Citations

This map shows the geographic impact of Saber İmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saber İmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saber İmani more than expected).

Fields of papers citing papers by Saber İmani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saber İmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saber İmani. The network helps show where Saber İmani may publish in the future.

Co-authorship network of co-authors of Saber İmani

This figure shows the co-authorship network connecting the top 25 collaborators of Saber İmani. A scholar is included among the top collaborators of Saber İmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saber İmani. Saber İmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
İmani, Saber, et al.. (2025). Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy. Frontiers in Cellular and Infection Microbiology. 14. 1501010–1501010. 26 indexed citations breakdown →
2.
İmani, Saber, et al.. (2024). Exploration of drug repurposing for Mpox outbreaks targeting gene signatures and host-pathogen interactions. Scientific Reports. 14(1). 29436–29436. 5 indexed citations
3.
Yu, Haojie, Yongchang Xu, Saber İmani, et al.. (2024). Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development. ACS Infectious Diseases. 10(7). 2336–2355. 7 indexed citations
4.
İmani, Saber, et al.. (2024). Current innovations in mRNA vaccines for targeting multidrug-resistant ESKAPE pathogens. Biotechnology Advances. 79. 108492–108492. 6 indexed citations
5.
Li, Xiaoping, et al.. (2023). Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid. Frontiers in Molecular Biosciences. 10. 1260883–1260883. 11 indexed citations
6.
Fu, Shangyi, Jiewen Fu, Khosrow Jadidi, et al.. (2023). Novel pathogenic CERKL variant in Iranian familial with inherited retinal dystrophies: genotype–phenotype correlation. 3 Biotech. 13(6). 166–166. 2 indexed citations
7.
Li, Xiaoping, et al.. (2023). Advances and Challenges in Cytomegalovirus Detection Methods for Liver Transplant Donors. Diagnostics. 13(21). 3310–3310. 3 indexed citations
8.
Guo, Rui, Tian Liu, Marzieh Dehghan Shasaltaneh, et al.. (2022). Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy. Frontiers in Oncology. 12. 829212–829212. 20 indexed citations
9.
İmani, Saber, Shuya Liu, Mazaher Maghsoudloo, & Qinglian Wen. (2022). Histochemical Staining of Vasculogenic Mimicry. Methods in molecular biology. 2514. 107–120. 2 indexed citations
10.
Yang, Juan, Zhouxue Wu, Yao Chen, et al.. (2020). Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer. Journal of Cancer Research and Clinical Oncology. 147(2). 411–422. 25 indexed citations
11.
Zeng, Qin, Yuan Li, Saber İmani, et al.. (2020). Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo. Journal of drug targeting. 28(9). 961–969. 12 indexed citations
12.
İmani, Saber, et al.. (2014). Comparison of IgG and IgA Antibodies Titrations against Helicobacter Pylori in Urban and Rural Populations in Mazandaran Province. SHILAP Revista de lepidopterología. 4(1). 50–57.
13.
İmani, Saber, et al.. (2011). Hg, Cd and Pb heavy metal bioremediation by Dunaliella alga. Journal of Medicinal Plants Research. 5(13). 2775–2780. 29 indexed citations
14.
İmani, Saber, et al.. (2011). Direct electron transfer of hemoglobin on nickel oxide nanoparticles modified graphite electrode. African Journal of Biochemistry Research. 5(6). 165–171. 4 indexed citations
15.
İmani, Saber, et al.. (2011). Antibacterial Effect of CrO and CoFe2O4 Nanoparticles upon Staphylococcus aureus. SHILAP Revista de lepidopterología. 2 indexed citations
16.
İmani, Saber, et al.. (2011). Synthetics of NiFe2O4 nanoparticles for recombinant His-tag protein purification. International journal of nanodimension.. 2(26). 129–135. 3 indexed citations
17.
İmani, Saber, et al.. (2011). Determining the antibacterial effect of ZnO nanoparticle against the pathogenic bacterium, Shigella dysenteriae (type 1). International journal of nanodimension.. 1(4). 279–285. 39 indexed citations
18.
İmani, Saber, Maryam Alsadat Hashemipour, & Roya Kelishadi. (2010). LIPID PROFILE OF CHILDREN WITH TYPE I DIABETES COMPARED TO CONTROLS. SHILAP Revista de lepidopterología. 4 indexed citations
19.
İmani, Saber, et al.. (2010). EFFECT OF AGE, GENDER AND BLOOD GROUP ON BLOOD CANCER TYPES. Trauma Monthly. 15(2). 111–114. 13 indexed citations
20.
Kelishadi, Roya, et al.. (2003). Survey of some metabolic disorders in obese children and adolescents. The Journal of Qazvin University of Medical Sciences. 7(26). 85–94. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026